Treatment with peginterferon alfa-2a (40KD) (PEGASYS®)...

Treatment with peginterferon alfa-2a (40KD) (PEGASYS®) results in improved rates of response compared to conventional interferon in patients with HBEAG positive chronic hepatitis B harboring HBV genotypes B or ‘difficult-to-treat’ genotype C

W.G.E. Cooksley, M.-Y. Lai, T. Piratvisuth, Y.-J. Wang, V. Mahachai, Y.-C. Chao, T. Tanwandee, A. Chutaputti, W.-Y. Chang, F.E. Zahm, N. Pluck
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
38
Year:
2003
Language:
english
DOI:
10.1016/s0168-8278(03)80483-x
File:
PDF, 135 KB
english, 2003
Conversion to is in progress
Conversion to is failed